1hyk
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:1hyk.gif|left|200px]] | [[Image:1hyk.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_1hyk", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | | | + | or leave the SCENE parameter empty for the default display. |
| - | | | + | --> |
| - | + | {{STRUCTURE_1hyk| PDB=1hyk | SCENE= }} | |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''AGOUTI-RELATED PROTEIN (87-132) (AC-AGRP(87-132))''' | '''AGOUTI-RELATED PROTEIN (87-132) (AC-AGRP(87-132))''' | ||
| Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1HYK is a [[Single protein]] structure | + | 1HYK is a [[Single protein]] structure. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=1qu8 1qu8]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HYK OCA]. |
==Reference== | ==Reference== | ||
| Line 31: | Line 28: | ||
[[Category: Trulson, J A.]] | [[Category: Trulson, J A.]] | ||
[[Category: Wilken, J.]] | [[Category: Wilken, J.]] | ||
| - | [[Category: | + | [[Category: Agouti]] |
| - | [[Category: | + | [[Category: Agouti-related]] |
| - | [[Category: | + | [[Category: Agrp]] |
| - | [[Category: | + | [[Category: Cysteine rich]] |
| - | [[Category: | + | [[Category: Disulfide bond]] |
| - | [[Category: | + | [[Category: Endogenous antagonist]] |
| - | [[Category: | + | [[Category: Ick]] |
| - | [[Category: | + | [[Category: Inhibitor cystine knot]] |
| - | [[Category: | + | [[Category: Melanocortin antagonist]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 19:21:50 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 16:21, 2 May 2008
AGOUTI-RELATED PROTEIN (87-132) (AC-AGRP(87-132))
Overview
The structure of the chemically synthesized C-terminal region of the human agouti related protein (AGRP) was determined by 2D 1H NMR. Referred to as minimized agouti related protein, MARP is a 46 residue polypeptide containing 10 Cys residues involved in five disulfide bonds that retains the biological activity of full length AGRP. AGRP is a mammalian signaling molecule, involved in weight homeostasis, that causes adult onset obesity when overexpressed in mice. AGRP was originally identified by homology to the agouti protein, another potent signaling molecule involved in obesity disorders in mice. While AGRP's exact mechanism of action is unknown, it has been identified as a competitive antagonist of melanocortin receptors 3 and 4 (MC3r, MC4r), and MC4r in particular is implicated in the hypothalamic control of feeding behavior. Full length agouti and AGRP are only 25% homologous, however, their active C-terminal regions are approximately 40% homologous, with nine out of the 10 Cys residues spatially conserved. Until now, 3D structures have not been available for either agouti, AGRP or their C-terminal regions. The NMR structure of MARP reported here can be characterized as three major loops, with four of the five disulfide bridges at the base of the structure. Though its fold is well defined, no canonical secondary structure is identified. While previously reported structural models of the C-terminal region of AGRP were attempted based on Cys homology between AGRP and certain toxin proteins, we find that Cys spacing is not sufficient to correctly determine the 3D fold of the molecule.
About this Structure
1HYK is a Single protein structure. This structure supersedes the now removed PDB entry 1qu8. Full crystallographic information is available from OCA.
Reference
NMR structure of a minimized human agouti related protein prepared by total chemical synthesis., Bolin KA, Anderson DJ, Trulson JA, Thompson DA, Wilken J, Kent SB, Gantz I, Millhauser GL, FEBS Lett. 1999 May 21;451(2):125-31. PMID:10371151 Page seeded by OCA on Fri May 2 19:21:50 2008
